Provided is a method of manufacturing a hyaluronate-coated high-functional suture and a high-functional suture manufactured thereby, and more particularly to a method of manufacturing a high-functional suture and a high-functional suture manufactured thereby, wherein a suture for internal and external surgery derived from a conventional chemical synthetic material is coated with a hyaluronate as a biocompatible material, thus improving biocompatibility, functionality and ease of use. Upon application of the hyaluronate-coated suture of the invention to the human body, the hyaluronate applied on the surface of the suture is rapidly swollen by body fluids and can thus function as a lubricant, thus being convenient to use by a surgical doctor and reducing the pain of a patient and maximizing the functions of skin filling or skin regeneration in the body.

A method for manufacturing a gold thread by spirally twisting together a plurality of gold rods. The method comprises passing a gold drawing material through a die aperture to form gold rods. Winding at least two of the gold rods on at least two gold rod receiving rollers. Receiving the gold rods from the receiving rollers and twisting the gold rods to form a gold thread. Winding the gold thread on a gold thread receiving roller and supplying the gold thread from the gold thread receiving roller to a cutter and cutting the gold thread into a certain length.

A method for manufacturing a gold thread by spirally twisting together a plurality of gold rods. The method comprises passing a gold drawing material through a die aperture to form gold rods. Winding at least two of the gold rods on at least two gold rod receiving rollers. Receiving the gold rods from the receiving rollers and twisting the gold rods to form a gold thread. Winding the gold thread on a gold thread receiving roller and supplying the gold thread from the gold thread receiving roller to a cutter and cutting the gold thread into a certain length.

The present invention relates to a medical thread which has on one end thereof a stopper that has a polygonal cross-section, and which exhibits excellent end adhesive force and penetration resistance, and to a manufacturing method for same.

The present invention relates to a medical thread which has on one end thereof a stopper that has a polygonal cross-section, and which exhibits excellent end adhesive force and penetration resistance, and to a manufacturing method for same.

Multifilament yarn constructions include a core part and a sheath part, the core part comprising a plurality of core filaments, and the sheath part comprising a plurality of sheath filaments. Furthermore, members comprising the multifilament yarn construction and uses of the multifilament yarn construction and the members are provided.

Multifilament yarn constructions include a core part and a sheath part, the core part comprising a plurality of core filaments, and the sheath part comprising a plurality of sheath filaments. Furthermore, members comprising the multifilament yarn construction and uses of the multifilament yarn construction and the members are provided.

Processes for making high-performance polyethylene multi-filament yarn are disclosed which include the steps of a) making a solution of ultra-high molar mass polyethylene in a solvent; b) spinning of the solution through a spinplate containing at least 5 spinholes into an air-gap to form fluid filaments, while applying a draw ratio DR.sub.fluid; c) cooling the fluid filaments to form solvent-containing gel filaments; d) removing at least partly the solvent from the filaments; and e) drawing the filaments in at least one step before, during and/or after said solvent removing, while applying a draw ratio DR.sub.solid of at least 4, wherein in step b) each spinhole comprises a contraction zone of specific dimension and a downstream zone of diameter Dn and length Dn with Ln/Dn of from 0 to at most 25, to result in a draw ratio DR.sub.fluid=DR.sub.sp*DR.sub.ag of at least 150, wherein DR.sub.sp is the draw ratio in the spinholes and DR.sub.ag is the draw ratio in the air-gap, with DR.sub.sp being greater than 1 and DR.sub.ag at least 1. High-performance polyethylene multifilament yarn, and semi-finished or end-use products containing said yarn, especially to ropes and ballistic-resistant composites, are also disclosed.

Processes for making high-performance polyethylene multi-filament yarn are disclosed which include the steps of a) making a solution of ultra-high molar mass polyethylene in a solvent; b) spinning of the solution through a spinplate containing at least 5 spinholes into an air-gap to form fluid filaments, while applying a draw ratio DR.sub.fluid; c) cooling the fluid filaments to form solvent-containing gel filaments; d) removing at least partly the solvent from the filaments; and e) drawing the filaments in at least one step before, during and/or after said solvent removing, while applying a draw ratio DR.sub.solid of at least 4, wherein in step b) each spinhole comprises a contraction zone of specific dimension and a downstream zone of diameter Dn and length Dn with Ln/Dn of from 0 to at most 25, to result in a draw ratio DR.sub.fluid=DR.sub.sp*DR.sub.ag of at least 150, wherein DR.sub.sp is the draw ratio in the spinholes and DR.sub.ag is the draw ratio in the air-gap, with DR.sub.sp being greater than 1 and DR.sub.ag at least 1. High-performance polyethylene multifilament yarn, and semi-finished or end-use products containing said yarn, especially to ropes and ballistic-resistant composites, are also disclosed.

A medical device includes a surgical needle, an elongated suture, and an intervening segment. The elongated suture has a first end proximate to the needle and a second end located away from the needle. The elongated suture also includes a plurality of fibers defining a mesh wall between the first and second ends. A plurality of pores extend through the mesh wall, at least some which are in the macroporous size range of greater than 200 microns for facilitating tissue integration when introduced into a body. The intervening segment is disposed between and connected to either or both ends of the elongated suture and the needle. The intervening segment includes one or more fibers of the plurality of fibers and has a cross-sectional dimension smaller than a cross-sectional dimension of the mesh wall such that the intervening segment facilitates indirect attachment of the elongated macroporous mesh suture to the needle.